• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Laboratory testing suggests human lung tissue unimpacted by blu vapor

Bioengineer by Bioengineer
June 11, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Credit: Imperial Brands Science

A new study by Imperial Brands, owners of leading vape brand blu, contributes to the increasing evidence base substantiating vaping’s harm reduction potential compared to smoking.

The research, presented at the 58th annual meeting of the Society of Toxicology earlier this year, compared the in-vitro toxicological responses of a 3D model of human lung tissue to myblu vapour and cigarette* smoke across a range of biological endpoints.

Cells were repeatedly exposed to either 30, 60 or 90 puffs of vapour, smoke and air over 4 weeks, and the results were conclusive. While myblu vapour delivered significantly more nicotine compared to the cigarette smoke, it did not trigger any significant toxicological responses under test conditions.

Arguably the most striking observation involved the cilia on the surface of the cells- mobile, hair-like structures that line the airways and lungs, helping keep them clear of mucus and dirt. After 4 weeks of repeated exposure to undiluted myblu vapour, there was no recorded decrease in either the number of cilia, or the number of ciliated cells. In fact, tissue integrity was indistinguishable from air control. The observations were in marked contrast to cigarette smoke’s negative impact on lung cells, even when diluted at 1:17 ratio.

Dr Roman Wieczorek, Group Biological & Toxicological Laboratory Manager at Imperial Brands Science and study author, commented: “Utilising state-of-the-art in-vitro methodologies based on TT21C principles, we continue to investigate the mechanistic effects of our Next-Generation Product (NPG) portfolio to substantiate its harm reduction potential”.

“Our ethical assays use cells derived from humans. This negates the need to test on animals, while targeting multiple endpoints of direct relevance to adult smokers.”

Dr Grant O’Connell, Head of Scientific Affairs at Imperial Brands, added: “Our process of scientific substantiation focuses on all aspects of population level harm reduction, allowing us to develop robust scientific evidence packages that demonstrate the risk-reduced potential of our NGPs.

“Unfortunately, media headlines based on misleading science containing non-realistic human exposures and extrapolated results continue to prove confusing and unhelpful at best and disastrous to the global public health agenda at worst.

“Imperial Brands and blu urge public health bodies, regulators and journalists across the world to cut through the misleading, agenda-driven murk and help us in our mission to deliver something better for the world’s smokers.”

###

* Kentucky Reference Cigarette (3R4F)

Media Contact
Rob Taylor
[email protected]

Original Source

http://www.imperialbrandsscience.com/content/dam/imperial-brands/sciences/Library/Publications_archive/NGPs/2019/SOT%202019-P337__E-cigarettes%20induce%20..._R.Wieczorek.pdf

Tags: AddictionAnimal Research/RightsBiochemistryMedicine/HealthPublic HealthSmoking/TobaccoToxicology
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Serum Markers Predict Atrial Fibrillation in Diabetes

August 2, 2025
blank

Amyloid Fibrils Connect CHCHD10, CHCHD2 to Neurodegeneration

August 2, 2025

Mapping the Human Hippocampus: Single-Nucleus to Spatial Transcriptomics

August 2, 2025

Boosting ADMET Predictions for Key CYP450s

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    45 shares
    Share 18 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Serum Markers Predict Atrial Fibrillation in Diabetes

Intrapleural Anti-VEGF Boosts Nab-Paclitaxel Efficacy

Amyloid Fibrils Connect CHCHD10, CHCHD2 to Neurodegeneration

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.